NPRA Banner

               
Product Search   QUEST3+ System   Enquiries   Sitemap  

Direktif memperketatkan penggunaan rosiglitazone dan memperkukuhkan amaran berkaitan dengan risiko kesan advers kardiovaskular pada sisip bungkusan semua produk rosiglitazone termasuk produk kombinasi

User Rating: 3 / 5

Star ActiveStar ActiveStar ActiveStar InactiveStar Inactive
 

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Site Last Modified

  • Last Modified: Friday 01 November 2024, 09:13:24.

Search

Main Menu English